These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The Fc portion of UV3, an anti-CD54 monoclonal antibody, is critical for its antitumor activity in SCID mice with human multiple myeloma or lymphoma cell lines. Coleman EJ, Brooks KJ, Smallshaw JE, Vitetta ES. J Immunother; 2006; 29(5):489-98. PubMed ID: 16971805 [Abstract] [Full Text] [Related]
6. Anti-CD54 (ICAM-1) has antitumor activity in SCID mice with human myeloma cells. Huang YW, Richardson JA, Vitetta ES. Cancer Res; 1995 Feb 01; 55(3):610-6. PubMed ID: 7834632 [Abstract] [Full Text] [Related]
10. The effect of methotrexate on the expression of cell adhesion molecules and activation molecule CD69 in psoriasis. Torres-Alvarez B, Castanedo-Cazares JP, Fuentes-Ahumada C, Moncada B. J Eur Acad Dermatol Venereol; 2007 Mar 01; 21(3):334-9. PubMed ID: 17309454 [Abstract] [Full Text] [Related]
12. Pan-selectin antagonism improves psoriasis manifestation in mice and man. Friedrich M, Bock D, Philipp S, Ludwig N, Sabat R, Wolk K, Schroeter-Maas S, Aydt E, Kang S, Dam TN, Zahlten R, Sterry W, Wolff G. Arch Dermatol Res; 2006 Feb 01; 297(8):345-51. PubMed ID: 16362415 [Abstract] [Full Text] [Related]
13. Attenuation of postlaminectomy epidural fibrosis with monoclonal antibodies against intercellular adhesion molecule-1 and CD-18. Sabuncuoğlu H, Bavbek M, Sabuncuoğlu B, Gadelha E, Köse K, Preul M. Spine J; 2007 Feb 01; 7(4):459-65. PubMed ID: 17630144 [Abstract] [Full Text] [Related]
14. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes. Albanesi C, De Pità O, Girolomoni G. Clin Dermatol; 2007 Feb 01; 25(6):581-8. PubMed ID: 18021896 [Abstract] [Full Text] [Related]
17. Immunomodulatory properties of FK734, a humanized anti-CD28 monoclonal antibody with agonistic and antagonistic activities. Shiao SL, McNiff JM, Masunaga T, Tamura K, Kubo K, Pober JS. Transplantation; 2007 Feb 15; 83(3):304-13. PubMed ID: 17297405 [Abstract] [Full Text] [Related]
18. A new therapeutic approach to treat psoriasis by inhibition of fatty acid oxidation by Etomoxir. Caspary F, Elliott G, Navé BT, Verzaal P, Rohrbach M, Das PK, Nagelkerken L, Nieland JD. Br J Dermatol; 2005 Nov 15; 153(5):937-44. PubMed ID: 16225603 [Abstract] [Full Text] [Related]
19. Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice. Bhagavathula N, Nerusu KC, Fisher GJ, Liu G, Thakur AB, Gemmell L, Kumar S, Xu ZH, Hinton P, Tsurushita N, Landolfi NF, Voorhees JJ, Varani J. Am J Pathol; 2005 Apr 15; 166(4):1009-16. PubMed ID: 15793282 [Abstract] [Full Text] [Related]
20. IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples. Piloto O, Nguyen B, Huso D, Kim KT, Li Y, Witte L, Hicklin DJ, Brown P, Small D. Cancer Res; 2006 May 01; 66(9):4843-51. PubMed ID: 16651440 [Abstract] [Full Text] [Related] Page: [Next] [New Search]